Vor Biopharma Inc. (VOR)
1.01
-0.07 (-6.48%)
At close: Mar 03, 2025, 11:37 AM
Vor Biopharma Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 3.49M | 8.96M | 4.45M | 1.39M | 91K | 20K |
| Gross Profit | -3.49M | -8.96M | -4.45M | -1.39M | -91K | -20K |
| Operating Income | -126.04M | -93.42M | -69.02M | -43.37M | -10.42M | -2.86M |
| Interest Income | 8.17M | 1.32M | 119K | 29K | 154K | n/a |
| Pretax Income | -117.86M | -92.09M | -68.9M | -43.34M | -10.84M | -4.15M |
| Net Income | -117.86M | -90.77M | -68.78M | -43.34M | -11.45M | -4.15M |
| Selling & General & Admin | 31.72M | 28.87M | 21.49M | 11.75M | 4.22M | 427K |
| Research & Development | 94.31M | 64.55M | 47.53M | 31.62M | 6.2M | 2.43M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 126.04M | 93.42M | 69.02M | 43.37M | 10.42M | 2.86M |
| Interest Expense | n/a | n/a | n/a | n/a | 608K | 1M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 126.04M | 93.42M | 69.02M | 43.37M | 10.42M | 2.86M |
| Income Tax | n/a | -1.32M | -119K | 427.7K | 608K | -289K |
| Shares Outstanding (Basic) | 67.19M | 39.55M | 37.17M | 37.13M | 37.12M | 5.66M |
| Shares Outstanding (Diluted) | 67.19M | 39.55M | 37.17M | 37.13M | 37.12M | 5.66M |
| EPS (Basic) | -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| EPS (Diluted) | -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| EBITDA | -114.37M | -90.89M | -67.58M | -41.95M | -10.17M | -2.84M |
| Depreciation & Amortization | 3.49M | 8.96M | 4.45M | 1.39M | 91K | 20K |